REGN
Regeneron Pharmaceuticals
Stock NASDAQ – Stock Market Prices, News & Analysis
Regeneron Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of treatments for serious diseases.
Regeneron Pharmaceuticals
REGN
Regeneron Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of treatments for serious diseases.
Price history of Regeneron Pharmaceuticals
Price history of Regeneron Pharmaceuticals
Performance & Momentum
Regeneron's Dupixent Approved in Japan, Outlook Steady
Regeneron Pharmaceuticals strengthens its position with Dupixent approval for children aged 6 to 11 with bronchial asthma in Japan, backed by phase 3 trials showing significant reduction in exacerbations and improved lung function. Morgan Stanley maintains a neutral rating while slightly raising its price target, citing reduced regulatory risks. The stock benefits from solid five-year growth, reflecting strong market confidence in its key franchises.
Strategic Analysis
Regeneron Pharmaceuticals • 2026
Regeneron Pharmaceuticals is an American biotechnology leader specializing in the development of innovative treatments for serious diseases, capitalizing on its ability to combine advanced research with effective commercialization. Its positioning is based on strong scientific expertise reinforced by a diversified portfolio of products in oncology, immunology, and ophthalmology.
Strengths
- Strong pipeline of innovative products supported by consistent R&D investments
- Proven ability to transform research into commercially viable treatments
- Therapeutic diversification reducing exposure to sector-specific risks
Weaknesses
- Sensitivity to regulatory regulations and decisions from health authorities
- Dependence on certain flagship products for a significant share of revenue
Momentum
Recent momentum reflects a renewed interest driven by the valuation of innovations and a moderate appreciation in the medium term. This dynamism encourages a thoughtful investment stance in a context where the valuation already integrates some of the expectations related to the commercialization of new treatments.
Similar stocks to Regeneron Pharmaceuticals
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
